The EPO published patent application EP4086282A1 for Merus B.V., titled 'Generation of Binding Molecules.' The patent covers binding molecules with applications in immunology, including treatments targeting C07K 16/10 (viral), C07K 16/28 (cell surface), and C07K 16/30 (tumor) classifications. Inventors include Throsby, Logtenberg, and De Kruif.

Pharmaceutical and biotechnology companies developing similar binding molecule technologies should review this patent for potential freedom-to-operate implications. The patent grants Merus exclusive rights across 31 designated contracting states including major EU markets. Third parties seeking to use similar technologies may need to pursue licensing arrangements or design-around strategies.